Shukla Sanjay's Form 4 filing
aTYR PHARMA INC (ATYR) · filed Dec 12, 2023
- Accession no.
- 0001209191-23-058377
- Filed
- Dec 12, 2023
- Trade date
- Dec 11-12, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $17.7K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shukla SanjayCIK 0001671026 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2023 | Common Stock | PPurchaseAcquired | +3,000 | $1.17 | +$3,510 | 94,173 | Direct | |
| Dec 12, 2023 | Common Stock | PPurchaseAcquired | +12,000 | $1.18 | +$14,160 | 106,173 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.